Trials / Completed
CompletedNCT00422734
Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life
Tadalafil 5 mg Once a Day Compared to Placebo in Improving Erectile Dysfunction and Sexual Quality of Life
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 342 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine if tadalafil 5 mg daily compared to placebo when given for 12 weeks improves getting and maintaining an erection in men with erectile dysfunction and if there are improvements in the sexual quality of life of the man and his female study partner
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tadalafil | 5 mg tadalafil tablet taken by mouth once a day for 12 weeks |
| DRUG | Placebo | placebo tablet taken by mouth once a day for 12 weeks |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2008-01-01
- Completion
- 2008-01-01
- First posted
- 2007-01-17
- Last updated
- 2009-06-10
- Results posted
- 2009-06-02
Locations
19 sites across 5 countries: United States, Austria, France, Germany, Mexico
Source: ClinicalTrials.gov record NCT00422734. Inclusion in this directory is not an endorsement.